Special issue: “Synthesis, Analysis and Applications of Cyclodextrins and Their Derivatives”
Molecules (mdpi) invites the submission of original research papers and review articles concerning innovative synthetic pathways for new CD derivatives,
A forum for researchers, students and applicants in the field of cyclodextrin technology
Molecules (mdpi) invites the submission of original research papers and review articles concerning innovative synthetic pathways for new CD derivatives,
This study employs a multiscale simulation approach to investigate the underlying mechanisms of reversible cross-linking behavior in polymer materials, spanning
Glutathione-responsive cyclodextrin nanosponges (CDNSs) exploit intracellular redox gradients via disulfide bond cleavage, enabling selective drug release in cancerous and inflammatory
CD was immobilized on the surface of zeolite particles by using crosslinking with citric, succinic or adipic acid to improve
Abzena company developed a series of antibody drug conjugates (ADCs) using IgG1, IgG2, IgG4, mAbs, and other antibodies modified with
Since the last review in the Cyclodextrin News summarizing the anti aging effects of retinol (Vitamin A) and its derivatives,
The 6th European Cyclodextrin Conference will be held in Santiago de Compostela between October 2–4, 2019. The following deadlines have
The idea of producing cyclodextrin-enabled edible film coating on food items to improve the shelf life goes back to 1983
A new open-access book on host-guest polymer complexes edited by A E. Tonelli, G. Narayanan and A. Gurarslan was published
There is a not extremely recent but certainly very interesting patent application related to a special use of cyclodextrins, namely
Researchers from Kumamoto University (Hidetoshi Arima, Keiichi Motoyama, Taishi Higashi) filed an international patent application on a novel synthesis of
Although there are several commercial examples for the uses of cyclodextrins as taste-masking agents (Nicorette, Ulgut, Zyrtec, etc), their use
Osaka University Hospital with the support of Daichii Sankyo is sponsoring a clinical trial on a vaccine against influenza virus.